Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT06208514
- Status
- Recruiting
Conditions
- Chronic Low Back Pain (CLBP)
- Chronic Pelvic Pain
- Fibromyalgia
- Lupus Erythematosus, Systemic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Brief pain exposure therapy (BPET) — BEHAVIORALParticipants will complete daily logs for 7-days pre-treatment baseline, along with 21 days during the intervention protocol (fibromyalgia participants only will complete the daily logs), and 7 for days post-treatment. Brief Pain Exposure Therapy will be given for 3 weeks, 1.5 hours per week, telehealth-based behavioral intervention for chronic pain. Session content will include pain neuroscience education, mindfulness meditation, and graded exposure techniques for improving tolerance of painful or feared activities. Participants will also be provided handouts and pre-recorded meditation and imagery scripts that participants can use to facilitate between-session practices. In addition, participants will complete surveys through-out the study.
Study Details
This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia (FM), Lupus, chronic pelvic pain, and chronic low back pain learn effective strategies for reducing pain, disability and other problems that can come with fibromyalgia, Lupus, chronic pelvic pain, and chronic low back pain (such as depression or anxiety).
Key Dates
- Start date
- Mar 4, 2024
- Status verified
- Dec 2025
- Primary completion
- Apr 30, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 125 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Brief pain exposure therapy (BPET)
Primary Outcome Measure
Change in pain intensity based on the Numeric Pain Rating Scale between day 1 (T1) and day 60 (T5) [ Time Frame: Day 1, Day 60 ]
Central Contacts
- Beth Banner734-998-5837
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | John Sturgeon, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
By research site
Related Studies
- Explosive Synchronization of Brain Network Activity in Chronic PainRecruiting · University of Michigan · Ann Arbor, Michigan
- Fibromyalgia Sleep A to ZZZ StudyRecruiting · University of Michigan · Ann Arbor, Michigan
- A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)PHASE2 · Recruiting · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Scottsdale, Arizona
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back PainPHASE3 · Recruiting · Eli Lilly and Company · Chandler, Arizona